MRX Financial Facts
Gross profit: 160.59MLoss from discontinued operations, net of income tax benefit: 0
See Full Income Statement
Deferred tax assets, net: 58.96M
Short Term Investments: 629.81M
See Full Balance Sheet
Earnings History for Medicis Pharmaceutical Corp. (MRX)
|
Expand Research on MRX
| Next EPS Date | 11/6/12 *Est. | EPS Growth Rate | -18.8% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +26.5% | Revenue Growth Rate | +3.2% *Last Qtr. |
| Average % Move 1-Wk after EPS | -3.1% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/8/12  |
Q212 | $0.52 | $0.46 | +$0.06 | $197M | $191.51M | N/A / N/A | = | +31.7% | Details | |
| 5/8/12 |
Q112 | $0.60 | $0.42 | +$0.18 | $201.7M | $185.15M | N/A / N/A | = | +17.2% | Details | |
| 2/27/12 |
 |
Q411 | $0.87 | $0.55 | +$0.32 | $180.7M | $179.2M | N/A / N/A | = | +29.9% | Details |
| 11/8/11 |
|
Q311 | $0.56 | $0.61 | -$0.05 | $184.7M | $187.06M | N/A / N/A | = | +15.7% | Details |
| 8/8/11 |
|
Q211 | $0.64 | $0.64 | $0.00 | $190.8M | $188.79M | N/A / N/A | = | +30.8% | Details |
| 5/5/11 |
|
Q111 | $0.50 | $0.49 | +$0.01 | $164.9M | $168.98M | N/A / N/A | = | +21.3% | Details |
| 2/25/11 |
|
Q410 | $0.60 | $0.60 | $0.00 | $182.1M | $184.16M | N/A / N/A | = | +72.1% | Details |
